Skip to main content
Premium Trial:

Request an Annual Quote

Warnex Sells Pathogen Dx Business to AES Labs for $859K

NEW YORK (GenomeWeb News) — Warnex has sold its pathogen-detection business to AES Laboratoire, a French lab-equipment supplier, for CAN$900,000 ($859,000) in cash.
 
Warnex CEO Mark Busgang said yesterday it transferred the assets last week, and said that the deal is part of his company’s strategy to focus on laboratory services.
 
Quebec-based Warnex said around CAN$300,000 is to be paid at closing, and the other two thirds of the price would be paid in two installments on the first and second anniversaries of the closing.
 
Terms of the agreement also call for AES to rent 4,300 square feet of Warnex’ manufacturing and lab facilities for as long as two years.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.